Cargando…
Elevated Proangiogenic Markers are Associated with Vascular Complications within Ghanaian Sickle Cell Disease Patients
Sickle cell disease (SCD) is an inherited blood disorder that can result in vasculopathy and end organ damage. Angiogenesis has been implicated as a key contributing factor to vascular mediated tissue injury in SCD. The relative plasma levels of angiopoietin-1 (Ang-1), angiopoietin-2 (Ang-2), and va...
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6164085/ https://www.ncbi.nlm.nih.gov/pubmed/29954157 http://dx.doi.org/10.3390/medsci6030053 |
_version_ | 1783359516163702784 |
---|---|
author | Antwi-Boasiako, Charles Frimpong, Emmanuel Gyan, Ben Kyei-Baafour, Eric Sey, Fredericka Dzudzor, Bartholomew Abdul-Rahman, Mubarak Dankwah, Gifty B. Otu, Kate H. Ndanu, Tom A. Campbell, Andrew D. Ekem, Ivy Donkor, Eric S. |
author_facet | Antwi-Boasiako, Charles Frimpong, Emmanuel Gyan, Ben Kyei-Baafour, Eric Sey, Fredericka Dzudzor, Bartholomew Abdul-Rahman, Mubarak Dankwah, Gifty B. Otu, Kate H. Ndanu, Tom A. Campbell, Andrew D. Ekem, Ivy Donkor, Eric S. |
author_sort | Antwi-Boasiako, Charles |
collection | PubMed |
description | Sickle cell disease (SCD) is an inherited blood disorder that can result in vasculopathy and end organ damage. Angiogenesis has been implicated as a key contributing factor to vascular mediated tissue injury in SCD. The relative plasma levels of angiopoietin-1 (Ang-1), angiopoietin-2 (Ang-2), and vascular endothelial growth factor (VEGF) greatly influence angiogenesis. Dysregulation of these growth factors, leading to a pro-angiogenic state in SCD patients, has been documented in the developed world but there is very little data in Africa. There is the need, therefore, for studies in Ghanaian SCD patients. The aim of this study was to assess plasma levels of Ang-1, Ang-2, and VEGF in homozygous (HbSS) SCD patients with or without complications and healthy controls (HbAA) in Ghana. The study was a case-control study involving 544 participants: 396 HbSS SCD patients and 148 HbAA healthy controls. The study was conducted at the Center for Clinical Genetics (Sickle Cell Clinic) and Accra Area Blood Centre for National Blood transfusion at the Korle-Bu Teaching Hospital, Accra, Ghana. The plasma levels of Ang-1, Ang-2, and VEGF of study participants were measured with a double sandwich enzyme-linked immunosorbent assay (ELISA) technique. Complete blood count (CBC) was measured with an autoanalyser. The mean plasma Ang-1, Ang-2, and VEGF were significantly higher in HbSS SCD patients with or without complications than healthy controls (p < 0.001). The Ang-2/Ang-1 ratio was significantly lower in the controls than the HbSS patients (p < 0.001). The Ang-2/Ang-1 ratio was higher in the HbSS patients with leg ulcers as compared with patients with other complications and healthy controls (p < 0.001). There were higher leucocyte counts in HbSS patients than healthy controls. Overall, there was elevated plasma levels of Ang-1, Ang-2, and VEGF in SCD patients. The higher Ang-2/Ang-1 plasma levels in patients with leg ulcers suggests a possible ongoing angiogenesis and response to inflammatory stimuli. The study provides a first report on plasma levels of angiopoietin-1, angiopoietin-2, and vascular endothelial growth factors in homozygous sickle cell disease patients in Ghana. |
format | Online Article Text |
id | pubmed-6164085 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-61640852018-10-10 Elevated Proangiogenic Markers are Associated with Vascular Complications within Ghanaian Sickle Cell Disease Patients Antwi-Boasiako, Charles Frimpong, Emmanuel Gyan, Ben Kyei-Baafour, Eric Sey, Fredericka Dzudzor, Bartholomew Abdul-Rahman, Mubarak Dankwah, Gifty B. Otu, Kate H. Ndanu, Tom A. Campbell, Andrew D. Ekem, Ivy Donkor, Eric S. Med Sci (Basel) Article Sickle cell disease (SCD) is an inherited blood disorder that can result in vasculopathy and end organ damage. Angiogenesis has been implicated as a key contributing factor to vascular mediated tissue injury in SCD. The relative plasma levels of angiopoietin-1 (Ang-1), angiopoietin-2 (Ang-2), and vascular endothelial growth factor (VEGF) greatly influence angiogenesis. Dysregulation of these growth factors, leading to a pro-angiogenic state in SCD patients, has been documented in the developed world but there is very little data in Africa. There is the need, therefore, for studies in Ghanaian SCD patients. The aim of this study was to assess plasma levels of Ang-1, Ang-2, and VEGF in homozygous (HbSS) SCD patients with or without complications and healthy controls (HbAA) in Ghana. The study was a case-control study involving 544 participants: 396 HbSS SCD patients and 148 HbAA healthy controls. The study was conducted at the Center for Clinical Genetics (Sickle Cell Clinic) and Accra Area Blood Centre for National Blood transfusion at the Korle-Bu Teaching Hospital, Accra, Ghana. The plasma levels of Ang-1, Ang-2, and VEGF of study participants were measured with a double sandwich enzyme-linked immunosorbent assay (ELISA) technique. Complete blood count (CBC) was measured with an autoanalyser. The mean plasma Ang-1, Ang-2, and VEGF were significantly higher in HbSS SCD patients with or without complications than healthy controls (p < 0.001). The Ang-2/Ang-1 ratio was significantly lower in the controls than the HbSS patients (p < 0.001). The Ang-2/Ang-1 ratio was higher in the HbSS patients with leg ulcers as compared with patients with other complications and healthy controls (p < 0.001). There were higher leucocyte counts in HbSS patients than healthy controls. Overall, there was elevated plasma levels of Ang-1, Ang-2, and VEGF in SCD patients. The higher Ang-2/Ang-1 plasma levels in patients with leg ulcers suggests a possible ongoing angiogenesis and response to inflammatory stimuli. The study provides a first report on plasma levels of angiopoietin-1, angiopoietin-2, and vascular endothelial growth factors in homozygous sickle cell disease patients in Ghana. MDPI 2018-06-27 /pmc/articles/PMC6164085/ /pubmed/29954157 http://dx.doi.org/10.3390/medsci6030053 Text en © 2018 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Antwi-Boasiako, Charles Frimpong, Emmanuel Gyan, Ben Kyei-Baafour, Eric Sey, Fredericka Dzudzor, Bartholomew Abdul-Rahman, Mubarak Dankwah, Gifty B. Otu, Kate H. Ndanu, Tom A. Campbell, Andrew D. Ekem, Ivy Donkor, Eric S. Elevated Proangiogenic Markers are Associated with Vascular Complications within Ghanaian Sickle Cell Disease Patients |
title | Elevated Proangiogenic Markers are Associated with Vascular Complications within Ghanaian Sickle Cell Disease Patients |
title_full | Elevated Proangiogenic Markers are Associated with Vascular Complications within Ghanaian Sickle Cell Disease Patients |
title_fullStr | Elevated Proangiogenic Markers are Associated with Vascular Complications within Ghanaian Sickle Cell Disease Patients |
title_full_unstemmed | Elevated Proangiogenic Markers are Associated with Vascular Complications within Ghanaian Sickle Cell Disease Patients |
title_short | Elevated Proangiogenic Markers are Associated with Vascular Complications within Ghanaian Sickle Cell Disease Patients |
title_sort | elevated proangiogenic markers are associated with vascular complications within ghanaian sickle cell disease patients |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6164085/ https://www.ncbi.nlm.nih.gov/pubmed/29954157 http://dx.doi.org/10.3390/medsci6030053 |
work_keys_str_mv | AT antwiboasiakocharles elevatedproangiogenicmarkersareassociatedwithvascularcomplicationswithinghanaiansicklecelldiseasepatients AT frimpongemmanuel elevatedproangiogenicmarkersareassociatedwithvascularcomplicationswithinghanaiansicklecelldiseasepatients AT gyanben elevatedproangiogenicmarkersareassociatedwithvascularcomplicationswithinghanaiansicklecelldiseasepatients AT kyeibaafoureric elevatedproangiogenicmarkersareassociatedwithvascularcomplicationswithinghanaiansicklecelldiseasepatients AT seyfredericka elevatedproangiogenicmarkersareassociatedwithvascularcomplicationswithinghanaiansicklecelldiseasepatients AT dzudzorbartholomew elevatedproangiogenicmarkersareassociatedwithvascularcomplicationswithinghanaiansicklecelldiseasepatients AT abdulrahmanmubarak elevatedproangiogenicmarkersareassociatedwithvascularcomplicationswithinghanaiansicklecelldiseasepatients AT dankwahgiftyb elevatedproangiogenicmarkersareassociatedwithvascularcomplicationswithinghanaiansicklecelldiseasepatients AT otukateh elevatedproangiogenicmarkersareassociatedwithvascularcomplicationswithinghanaiansicklecelldiseasepatients AT ndanutoma elevatedproangiogenicmarkersareassociatedwithvascularcomplicationswithinghanaiansicklecelldiseasepatients AT campbellandrewd elevatedproangiogenicmarkersareassociatedwithvascularcomplicationswithinghanaiansicklecelldiseasepatients AT ekemivy elevatedproangiogenicmarkersareassociatedwithvascularcomplicationswithinghanaiansicklecelldiseasepatients AT donkorerics elevatedproangiogenicmarkersareassociatedwithvascularcomplicationswithinghanaiansicklecelldiseasepatients |